148 related articles for article (PubMed ID: 20097802)
1. Lung injury following thoracoscopic talc insufflation: experience of a single North American center.
Gonzalez AV; Bezwada V; Beamis JF; Villanueva AG
Chest; 2010 Jun; 137(6):1375-81. PubMed ID: 20097802
[TBL] [Abstract][Full Text] [Related]
2. Complications of talc poudrage in the United States.
Aelony Y
Chest; 2011 Feb; 139(2):477. PubMed ID: 21285069
[No Abstract] [Full Text] [Related]
3. Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis.
Zhang W; Zhao YL; Li SJ; Zhao YN; Guo NN; Liu B
J Cardiothorac Surg; 2021 May; 16(1):125. PubMed ID: 33947423
[TBL] [Abstract][Full Text] [Related]
4. Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc.
Shinno Y; Kage H; Chino H; Inaba A; Arakawa S; Noguchi S; Amano Y; Yamauchi Y; Tanaka G; Nagase T
Respirology; 2018 Jan; 23(1):55-59. PubMed ID: 28980363
[TBL] [Abstract][Full Text] [Related]
5. Thoracoscopy talc poudrage : a 15-year experience.
de Campos JR; Vargas FS; de Campos Werebe E; Cardoso P; Teixeira LR; Jatene FB; Light RW
Chest; 2001 Mar; 119(3):801-6. PubMed ID: 11243960
[TBL] [Abstract][Full Text] [Related]
6. Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study.
Bridevaux PO; Tschopp JM; Cardillo G; Marquette CH; Noppen M; Astoul P; Driesen P; Bolliger CT; Froudarakis ME; Janssen JP
Eur Respir J; 2011 Oct; 38(4):770-3. PubMed ID: 21436351
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
8. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.
Dresler CM; Olak J; Herndon JE; Richards WG; Scalzetti E; Fleishman SB; Kernstine KH; Demmy T; Jablons DM; Kohman L; Daniel TM; Haasler GB; Sugarbaker DJ; ; ; ;
Chest; 2005 Mar; 127(3):909-15. PubMed ID: 15764775
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax.
Györik S; Erni S; Studler U; Hodek-Wuerz R; Tamm M; Chhajed PN
Eur Respir J; 2007 Apr; 29(4):757-60. PubMed ID: 17182650
[TBL] [Abstract][Full Text] [Related]
10. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.
Debeljak A; Kecelj P; Triller N; Letonja S; Kern I; Debevec L; Rozman A
J BUON; 2006; 11(4):463-7. PubMed ID: 17309178
[TBL] [Abstract][Full Text] [Related]
11. Thoracoscopic talc pleurodesis for the treatment of spontaneous pneumothorax.
Pletinckx P; Muysoms F; De Decker C; Daeter E; Claeys D
Acta Chir Belg; 2005; 105(5):504-7. PubMed ID: 16315834
[TBL] [Abstract][Full Text] [Related]
12. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.
Janssen JP; Collier G; Astoul P; Tassi GF; Noppen M; Rodriguez-Panadero F; Loddenkemper R; Herth FJ; Gasparini S; Marquette CH; Becke B; Froudarakis ME; Driesen P; Bolliger CT; Tschopp JM
Lancet; 2007 May; 369(9572):1535-1539. PubMed ID: 17482984
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer.
Milanez RC; Vargas FS; Filomeno LB; Teixeira LR; Fernandez A; Jatene F; Light RW
Cancer; 1995 Jun; 75(11):2688-92. PubMed ID: 7743471
[TBL] [Abstract][Full Text] [Related]
14. Thoracoscopy. A prospective study of safety and outcome.
Colt HG
Chest; 1995 Aug; 108(2):324-9. PubMed ID: 7634861
[TBL] [Abstract][Full Text] [Related]
15. Talc pleurodesis in pleuropulmonary diseases treatment.
Ramić N; Krdžalić G; Mušanović N; Konjić F; Umihanić S; Ramić S; Mustedanagić-Mujanović J; Ljuca F; Zerem E
Med Glas (Zenica); 2014 Aug; 11(2):264-9. PubMed ID: 25082238
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
Verma A; Taha A; Venkateswaran S; Tee A
Singapore Med J; 2015 May; 56(5):268-73. PubMed ID: 26034319
[TBL] [Abstract][Full Text] [Related]
17. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.
Hartman DL; Gaither JM; Kesler KA; Mylet DM; Brown JW; Mathur PN
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):743-7; discussion 747-8. PubMed ID: 7682268
[TBL] [Abstract][Full Text] [Related]
18. Thoracoscopic talc poudrage pleurodesis for chronic recurrent pleural effusions.
Aelony Y; King R; Boutin C
Ann Intern Med; 1991 Nov; 115(10):778-82. PubMed ID: 1929026
[TBL] [Abstract][Full Text] [Related]
19. [Thoracoscopic pleurodesis in malignant pleural effusions].
Mitrofan C; Aldea A; Grigorescu C; Jitaru I; Iosep G; Aramă A; Danciu CE; Bolog S; Mihăescu T
Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):799-803. PubMed ID: 16612848
[TBL] [Abstract][Full Text] [Related]
20. A case of acute pneumonitis following talc pleurodesis: high-resolution CT findings.
Kim Y; Kim YK; Choi MY; Lee KE
J Thorac Imaging; 2006 Mar; 21(1):47-9. PubMed ID: 16538157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
